Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC9A5 |
| Upstream (Parents) |
|---|
| (<<) PCDHA1///PCDHA2///PCDHA3///PCDHA4///PCDHA5///PCDHA6///PCDHA7///PCDHA8///PCDHA10///PCDHA11///PCDHA12///PCDHA13///PCDHAC1///PCDHAC2///PCDHA9 → SLC9A5 |
| (<<) C22orf46 → SLC9A5 |
| (<<) ANXA6 → SLC9A5 |
| (<<) TIAM2 → SLC9A5 |
| (<<) SAR1A → SLC9A5 |
| (<<) DNAH2 → SLC9A5 |
| (<<) FAM105A → SLC9A5 |
| (<<) LRP4 → SLC9A5 |
| (<<) GULP1 → SLC9A5 |
| (<<) CASS4 → SLC9A5 |
| Downstream (Children) |
|---|
| (no edges) |
